Home
Nectar Lifescience Ltd PE Ratio

Nectar Lifescience Ltd
NSE: NECLIFE
PE
Key Highlights
- The P/E Ratio of Nectar Lifescience Ltd is 38.1 as of 22 Feb 12:11 PM .
- The P/E Ratio of Nectar Lifescience Ltd changed from 7 on March 2020 to 136.9 on March 2024 . This represents a CAGR of 81.24% over 5 years.
- The Latest Trading Price of Nectar Lifescience Ltd is ₹ 28.98 as of 21 Feb 15:30 .
- The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
- The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.
Historical P/E Ratio of Nectar Lifescience Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Nectar Lifescience Ltd
Company Fundamentals for Nectar Lifescience Ltd

Nectar Lifescience Ltd
NSE: NECLIFE
Share Price
Market Price of Nectar Lifescience Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Feb 2025 | 28.98 |
20 Feb 2025 | 29.76 |
19 Feb 2025 | 29.26 |
18 Feb 2025 | 27.37 |
17 Feb 2025 | 29.52 |
14 Feb 2025 | 30.06 |
13 Feb 2025 | 32.62 |
12 Feb 2025 | 32.18 |
11 Feb 2025 | 32.68 |
10 Feb 2025 | 35.9 |
SWOT Analysis Of Nectar Lifescience Ltd
BlinkX Score for Nectar Lifescience Ltd
Asset Value vs Market Value of Nectar Lifescience Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/E Ratio
Company | Market Cap | PE Ratio |
---|
Nectar Lifescience Ltd | 649.91 | 38.13 |
Sun Pharmaceuticals Industries Ltd | 394223 | 33.4 |
Divis Laboratories Ltd | 152610 | 73.8 |
Cipla Ltd | 119067 | 23.9 |
Torrent Pharmaceuticals Ltd | 102739 | 55.2 |
Dr Reddys Laboratories Ltd | 96124 | 17.9 |
Company | |
---|---|
Nectar Lifescience Ltd | 649.91 |
Sun Pharmaceuticals Industries Ltd | 394223 |
Divis Laboratories Ltd | 152610 |
Cipla Ltd | 119067 |
Torrent Pharmaceuticals Ltd | 102739 |
Dr Reddys Laboratories Ltd | 96124 |
PE Ratio of Nectar Lifescience Ltd Explained
₹649.91
Market cap
₹17
Earnings
38.1X
PE Ratio
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.
P/E Ratio Formula
P/E ratio = (CMP of share/ Earning per share)
Types of Price to Earning Ratio
1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
PE Ratio of Pharmaceuticals Industry over time
PE Ratio of Top Sectors
Historical Market Cap of Nectar Lifescience Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Nectar Lifescience Ltd
Historical Revenue, EBITDA and Net Profit of Nectar Lifescience Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Nectar Lifescience Ltd
Revenue
EBITDA
Net Profit
Historical Dividend Payout of Nectar Lifescience Ltd
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
Historical Dividend Payout of Nectar Lifescience Ltd
About Nectar Lifescience Ltd
- Nectar Lifescience Limited was incorporated on June 27, 1995 with the name 'Surya Medicare Limited'.
- On March 26, 2004, Company changed their name from 'Surya Medicare Limited' to 'Nectar Lifescience Limited'.
- NECLIFE is an integrated pharmaceutical organization, engaged in manufacturing and delivering high quality pharmaceutical products.
- It is a global pharmaceutical company specializing in Cephalosporins.
- Nectar excels in Cephalosporin APIs production with certified facilities meeting global standards.
Nectar Lifescience Ltd News Hub
Nectar Lifescience to conduct AGM
Nectar Lifescience announced that the Annual General Meeting (AGM) of the company will be held on 21
Read more
20 Aug 24
Nectar Lifescience to convene AGM
Nectar Lifescience announced that the Annual General Meeting (AGM) of the company will be held on 21
Read more
20 Aug 24
Nectar Lifescience consolidated net profit rises 63.19% in the June 2024 quarter
Net profit of Nectar Lifescience rose 63.19% to Rs 2.97 crore in the quarter ended June 2024 as agai
Read more
14 Aug 24
Nectar Lifescience to conduct board meeting
Nectar Lifescience will hold a meeting of the Board of Directors of the Company on 14 August 2024. P
Read more
06 Aug 24